TeselaGen Blog & articles

TeselaGen BioTech CEO Eduardo Abeliuk on the Future of AI

Dr. Eduardo Abeliuk is a U.S. based entrepreneur and technologist with over twenty years of experience driving technology development and innovation at various high-tech companies in the US. He is currently the Chairman and CEO at TeselaGen Biotech., a Silicon Valley based company that works at the interface between Biotechnology, Artificial Intelligence and Enterprise Software.

Read More »

Solving biotech challenges with AI

Biotechnology has enormous potential to solve some of the world’s most pressing challenges in health, food security, and the environment. Yet conventional methods for developing biotechnology products rely on trial-and-error based processes, which are slow and laborious. Through biological design automation, innovative and successful products can be developed at unprecedented speed.

Read More »

IPI: The Future of AI in Biotechnology

The artificial intelligence revolution kicked into high gear seemingly overnight. Generative AI platforms like ChatGPT and Google Bard have dominated headlines for months as we explore the possibilities for this powerful new technology, which has potentially significant implications for nearly every industry on the planet.

Read More »

Unlocking the Potential of Molecular Cloning: A Look at 5 Popular Plasmids and Their Functions

Plasmids are a crucial tool for molecular cloning in genetic engineering. They are small, circular, double-stranded DNA molecules that can replicate independently within bacterial cells. Plasmids can be modified with a variety of genetic elements, making them versatile vehicles for gene expression, protein production, and more. In this article, we will discuss five popular plasmids that are commonly used in molecular cloning.

Read More »


We're committed to your privacy. TeselaGen uses the information you provide to us to contact you about our relevant content, products, and services. You may unsubscribe from these communications at any time.